BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15137963)

  • 41. Intraepidermal adenocarcinoma in the perianal skin of two cats, a condition resembling human extramammary Paget's disease.
    Hargis AM; Baldessari AE; Walder EJ
    Vet Dermatol; 2008 Feb; 19(1):31-7. PubMed ID: 18177290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.
    Suman VJ; Dueck A; Sargent DJ
    Cancer Invest; 2008 Jun; 26(5):439-44. PubMed ID: 18568764
    [No Abstract]   [Full Text] [Related]  

  • 43. Warty and clear cell Bowen's disease.
    Hernández-Pérez E; Figueroa DE
    Int J Dermatol; 2005 Jul; 44(7):586-7. PubMed ID: 15985030
    [No Abstract]   [Full Text] [Related]  

  • 44. Invasive squamous cell carcinoma arising in refractory perianal Bowen's disease in a HIV-positive individual.
    Herat A; Shirato K; Damian DL; Finlayson R; Whitfeld M
    Australas J Dermatol; 2006 May; 47(2):120-3. PubMed ID: 16637809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anal malignant melanoma.
    Panda K; Devi A; Mohanty B; Mishra G
    J Indian Med Assoc; 1980 Oct; 75(8):167. PubMed ID: 7264332
    [No Abstract]   [Full Text] [Related]  

  • 46. [Results of a multi-year use of combined laser-surgical treatment in tumors of the epibulbar and limbocorneal localizations].
    Georgieva VB; Ziangirova GG; Kasparov AA
    Vestn Oftalmol; 2004; 120(5):3-5. PubMed ID: 15529527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimising the design of phase II oncology trials: the importance of randomisation.
    Ratain MJ; Sargent DJ
    Eur J Cancer; 2009 Jan; 45(2):275-80. PubMed ID: 19059773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties.
    Michaelis LC; Ratain MJ
    Clin Cancer Res; 2007 Apr; 13(8):2400-5. PubMed ID: 17438099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer of the anal canal (cancer of the anus).
    Peiffert D; Brunet P; Salmon R; Hannoun JM; Giovannini M
    Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S52-2S56. PubMed ID: 17151563
    [No Abstract]   [Full Text] [Related]  

  • 50. Case of Bowen's disease occurring in an old Bacille Calmette-Guerin vaccination site.
    Miyakura T; Yamamoto T; Tsuboi R
    J Dermatol; 2007 Jun; 34(6):416-7. PubMed ID: 17535414
    [No Abstract]   [Full Text] [Related]  

  • 51. Randomized phase II trials with a prospective control.
    Jung SH
    Stat Med; 2008 Feb; 27(4):568-83. PubMed ID: 17573688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimal and minimax three-stage designs for phase II oncology clinical trials.
    Chen K; Shan M
    Contemp Clin Trials; 2008 Jan; 29(1):32-41. PubMed ID: 17544337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel designs and end points for phase II clinical trials.
    Adjei AA; Christian M; Ivy P
    Clin Cancer Res; 2009 Mar; 15(6):1866-72. PubMed ID: 19276272
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II clinical trials in oncology: strengths and limitations of two-stage designs.
    Schlesselman JJ; Reis IM
    Cancer Invest; 2006; 24(4):404-12. PubMed ID: 16777694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Designing phase II studies in cancer with time-to-event endpoints.
    Owzar K; Jung SH
    Clin Trials; 2008; 5(3):209-21. PubMed ID: 18559409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phase II trials in journal of clinical oncology.
    Cannistra SA
    J Clin Oncol; 2009 Jul; 27(19):3073-6. PubMed ID: 19451415
    [No Abstract]   [Full Text] [Related]  

  • 57. A parallel phase I/II clinical trial design for combination therapies.
    Huang X; Biswas S; Oki Y; Issa JP; Berry DA
    Biometrics; 2007 Jun; 63(2):429-36. PubMed ID: 17688495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Surgical treatment of anal cancer].
    Pettavel J
    Praxis; 1968 Jul; 57(29):1029-31. PubMed ID: 5755473
    [No Abstract]   [Full Text] [Related]  

  • 59. Randomized phase II designs in cancer clinical trials: current status and future directions.
    Lee JJ; Feng L
    J Clin Oncol; 2005 Jul; 23(19):4450-7. PubMed ID: 15994154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anorectal miscellany: pilonidal disease, anal cancer, Bowen's and Paget's diseases, foreign bodies, and hidradenitis suppurativa.
    Billingham RP
    Prim Care; 1999 Mar; 26(1):171-7. PubMed ID: 9922300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.